EUVIMEDOtkrijte EUVIMED
EUVIMED · CrossrefJournal

Annals of Hematology

ISSN 0939-5555 · Springer Science and Business Media LLC

Latest articles

  1. VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML

    Lydia Kretschmer, Leo Ruhnke, Christoph Schliemann, Lars Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, Christoph Schmid, Maher Hanoun, Tim Sauer, Klaus H. Metzeler, Kerstin Schäfer-Eckart, Mathias Hänel, Martina Crysandt, Paul Jäger, Stefan W. Krause, Christine Dierks, Stefan Klein, Nadia Maguire, Lukas P. Frenzel, Veit L. Bücklein, Wolfgang Blau, Ulrich Kaiser, Kai Wegehenkel, Alexander Höllein, Ruth Seggewiss-Bernhardt, Wenke Markgraf, Frank Fiebig, Anna Harig, Katharina Schmidt-Brücken, Christian Thiede, Jan Moritz Middeke, Richard Dillon, Claudia D. Baldus, Hubert Serve, Karsten Spiekermann, Wolfgang Hiddemann, Richard F. Schlenk, Carsten Müller-Tidow, Martin Bornhäuser

    Published: 2025-07DOI: 10.1007/s00277-025-06496-7

Volumes

2026 · 12025 · 4312024 · 6752023 · 4342022 · 3942021 · 3872020 · 3872019 · 3702018 · 3202017 · 3142016 · 3262015 · 3402014 · 3292013 · 2762012 · 3012011 · 2432010 · 2322009 · 2192008 · 1892007 · 1452006 · 1932005 · 1822004 · 1702003 · 1862002 · 1692001 · 1982000 · 1311999 · 1101998 · 1111997 · 1061996 · 1421995 · 2241994 · 1591993 · 1321992 · 1411991 · 122

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.